Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01729754
Brief Title: A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011) (reSURFACE 2)

First Submitted : November 13, 2012
First Submitted that Met QC Criteria : November 14, 2012
First Posted : November 20, 2012 (Estimate)

Results First Submitted : April 10, 2018
Results First Submitted that Met QC Criteria : May 25, 2018
Results First Posted : June 27, 2018

Last Update Submitted that Met QC Criteria : February 23, 2022
Last Update Posted : March 8, 2022